A bit of bisexual mythbusting inspired by Halsey.

People seem to have a lot of misconceptions about what it means to be bisexual. Thankfully, pop star Halsey is here to clear things up.

On Twitter, the "Bad at Love" singer joked, "So if I'm dating a guy, I'm straight, and if I date a woman, I'm a lesbian. The only way to be a #True bisexual is to date two people at once."

Believe it or not, this is not how bisexuality works. Bisexual people in monogamous relationships don't "become" gay or straight based on who their partner is at any given time. A bisexual woman might date a lesbian woman, or she might date another bisexual woman, or she might date a straight man. No matter who her parter is, she's still bisexual.


Fellow bi icon ("bi-con?"), actor Evan Rachel Wood, jumped in with another joke rolling her eyes at some of the totally frustrating misconceptions people have about bisexuals.

Since there seems to be a bit of confusion about the B in LGBTQ, let's break down seven other majorly common myths people have on the topic.

1. "There's no such thing as bisexuality."

This is silly. In fact, a 2011 study by the Williams Institute found there are actually more bisexual people than there are gay and lesbian individuals combined. If you believe gay and lesbian people exist (which, yeah, of course they do), there's really no reason to doubt the existence of the bi folks of the world.

2. "Bisexuals have it easy compared with gay men and lesbian women."

It's easy to understand where this line of thinking comes from. In theory, bisexual people can just "blend in" as straight if and when it's convenient for them. The truth is a lot more complicated than that. A 2011 Centers for Disease Control report of high school students found that bisexual individuals are more likely to be victims of intimate partner violence (23% of bi people surveyed) than their gay and lesbian counterparts (20% of those surveyed). Much like other members of the LGBTQ community, bi individuals experience high levels of discrimination in  health care, employment, and housing.

Halsey performs at Coachella in 2016. Photo by Frazer Harrison/Getty Images for Coachella.

3. "Bisexuals are just gay or lesbian but don't want to admit it."

This line is pretty easily debunked by looking at a 2013 Pew Research Center report that found that out of self-identified bisexual individuals in committed relationships, 84% were paired with someone of the opposite sex and just 9% were in a same-sex relationship. Some might conclude from this data that bisexuals are actually straight and not bi at all, but that's also flawed. What's likely is that bi individuals tend to be in opposite-sex relationships simply because the dating pool is larger.

4. "Bisexuals are more likely to cheat in monogamous relationships."

The bi-person-as-greedy-sex-fiend myth goes way back, but there's never been any firm data to support that nor is there much in the way of supporting this idea that bisexuals are anti-monogamy as a whole.

5. "Being bisexual excludes non-binary trans people."

This isn't necessarily true. While some people prefer the term "pansexual" as a way of describing attraction to people of all genders, plenty of bisexual people are perfectly accepting of trans people. The idea behind this is that since the word "bisexual" has "bi" in it, that it's an attraction to two options: men and women. There's another way of looking at it, however. Here's how the American Institute of Bisexuality defines the term (emphasis added):

"Bisexuality describes anyone whose attractions are not limited to one sex. The term comes to us from the world of science and describes a person with both homosexual (lit. same sex) and heterosexual (lit. different sex) attractions."

People carry a bisexual flag during the 2013 LA Pride Parade. Photo by David McNew/Getty Images.

6. "You're not bisexual unless you're equally attracted to men and women."

While it's true that some bi people are equally attracted to men and women (and, taking a cue from point #5, non-binary people), it's not true for all. It's not always a 50-50 split; some might lean 90-10 toward men or 75-25 toward women, and for some people, it might be a constantly changing and shifting ratio. If you're attracted to people of the same and different genders as you, the bisexual label is yours to claim (if you want it).

7. "You're not bisexual unless you've dated men and women."

The truth is that you don't need to have dated or been physically intimate with anyone. Most straight people know they're straight before they're ever in a straight relationship; certainly, there are gay people who know they're gay before they've ever been intimate with someone else; so why would it be any different for bi folks? Your identity is yours alone, and anyone who tries to tell you otherwise can take a hike.

Evan Rachel Wood at the 2016 premiere of "Westworld." Photo by Alberto E. Rodriguez/Getty Images.

Hopefully, the ever-increasing visibility of bi people in the public spotlight will lead to a drop in some of these misconceptions and harmful stereotypes. It's been great seeing shows like "Crazy Ex-Girlfriend" and "Brooklyn 99" include some myth-busting and accurate depictions of bi characters, but there's certainly a long way to go before "So, like, are you really just gay?" questions become a thing of the past.

One day, the myths will all be busted. Until then, Evan Rachel Wood, Halsey, and the rest of us bi folks will have to commiserate over a few snarky tweets.

Everyone can all use a little lift at the end of the week, and we've collected some of this week's best stories to provide just such a pick-me-up. Here are 10 things we want to share, just because they made us so darn happy.

1. Introducing Lila, the U.S. Capitol Police's first emotional support dog.

After the traumatic experiences of January 6th, Capitol Police officers could definitely use some extra support. Lila, a two-year-old black lab, will now serve as the department's first full-time emotional support dog. Look at that sweet face!

2. Speaking of the Capitol, take a look at this week's gorgeous solar eclipse behind the dome.

NASA Administrator Bill Nelson shared the stunning "ring of fire" image on Twitter. Always a treat when nature gives us a great show.


3. Colorado sees its first wild wolf pups in six decades.

In the 1940s, the gray wolf was eradicated in Colorado by trappers and hunters, with the support of the federal government. Whoops. This week, Colorado Parks and Wildlife has announced the first evidence of wild wolf breeding in the state, a sign of hope for the endangered species. Read more about the discovery here.

Photo by M L on Unsplash


4. 30-year-old singer with terminal cancer amazed and inspired with her performance on America's Got Talent.

Keep Reading Show less

Everyone can all use a little lift at the end of the week, and we've collected some of this week's best stories to provide just such a pick-me-up. Here are 10 things we want to share, just because they made us so darn happy.

1. Introducing Lila, the U.S. Capitol Police's first emotional support dog.

After the traumatic experiences of January 6th, Capitol Police officers could definitely use some extra support. Lila, a two-year-old black lab, will now serve as the department's first full-time emotional support dog. Look at that sweet face!

2. Speaking of the Capitol, take a look at this week's gorgeous solar eclipse behind the dome.

NASA Administrator Bill Nelson shared the stunning "ring of fire" image on Twitter. Always a treat when nature gives us a great show.


3. Colorado sees its first wild wolf pups in six decades.

In the 1940s, the gray wolf was eradicated in Colorado by trappers and hunters, with the support of the federal government. Whoops. This week, Colorado Parks and Wildlife has announced the first evidence of wild wolf breeding in the state, a sign of hope for the endangered species. Read more about the discovery here.

Photo by M L on Unsplash


4. 30-year-old singer with terminal cancer amazed and inspired with her performance on America's Got Talent.

Keep Reading Show less
True

Each year, an estimated 1.8 million people in the United States are affected by cancer — most commonly cancers of the breast, lung, prostate, and blood cancers such as leukemia. While not everyone overcomes the disease, thanks to science, more people are surviving — and for longer — than ever before in history.

We asked three people whose lives have been impacted by cancer to share their stories – how their lives were changed by the disease, and how they're using that experience to change the future of cancer treatments with the hope that ultimately, in the fight against cancer, science will win. Here's what they had to say.

Celine Ryan, 55, engineer database programmer and mother of five from Detroit, MI

Photo courtesy of Celine Ryan

In September 2013, Celine Ryan woke up from a colonoscopy to some traumatic news. Her gastroenterologist showed her a picture of the cancerous mass they found during the procedure.

Ryan and her husband, Patrick, had scheduled a colonoscopy after discovering some unusual bleeding, so the suspicion she could have cancer was already there. Neither of them, however, were quite prepared for the results to be positive -- or for the treatment to begin so soon. Just two days after learning the news, Ryan had surgery to remove the tumor, part of her bladder, and 17 cancerous lymph nodes. Chemotherapy and radiation soon followed.

Ryan's treatment was rigorous – but in December 2014, she got the devastating news that the cancer, once confined to her colon, had spread to her lungs. Her prognosis, they said, was likely terminal.

But rather than give up hope, Ryan sought support from online research, fellow cancer patients and survivors, and her medical team. When she brought up immunotherapy to her oncologist, he quickly agreed it was the best course of action. Ryan's cancer, like a majority of colon and pancreatic cancers, had been caused by a defect on the gene KRAS, which can result in a very aggressive cancer that is virtually "undruggable." According to the medical literature, the relatively smooth protein structure of the KRAS gene meant that designing inhibitors to bind to surface grooves and treat the cancer has been historically difficult. Through her support systems, Ryan discovered an experimental immunotherapy trial at the National Institutes of Health (NIH) in Bethesda, MD., and called them immediately to see if she was eligible. After months of trying to determine whether she was a suitable candidate for the experimental treatment, Ryan was finally accepted.

The treatment, known as tumor-infiltrating lymphocyte therapy, or TIL, is a testament to how far modern science has evolved. With this therapy, doctors remove a tumor and harvest special immune cells that are found naturally in the tumor. Doctors then grow the cells in a lab over the next several weeks with a protein that promotes rapid TIL growth – and once the cells number into the billions, they are infused back into the patient's body to fight the cancer. On April 1, 2015, Ryan had her tumor removed at the NIH. Two months later, she went inpatient for four weeks to have the team "wash out" her immune system with chemotherapy and infuse the cells – all 148 billion of them – back into her body.

Six weeks after the infusion, Ryan and Patrick went back for a follow-up appointment – and the news they got was stunning: Not only had no new tumors developed, but the six existing tumors in her lungs had shrunk significantly. Less than a year after her cell infusion, in April 2016, the doctors told Ryan news that would have been impossible just a decade earlier: Thanks to the cell infusion, Ryan was now considered NED – no evaluable disease. Her body was cancer-free.

Ryan is still NED today and continuing annual follow-up appointments at the NIH, experiencing things she never dreamed she'd be able to live to see, such as her children's high school and college graduations. She's also donating her blood and cells to the NIH to help them research other potential cancer treatments. "It was an honor to do so," Ryan said of her experience. "I'm just thrilled, and I hope my experience can help a lot more people."

Patrice Lee, PhD, VP of Pharmacology, Toxicology and Exploratory Development at Pfizer

Photo courtesy of Patrice Lee

Patrice Lee got into scientific research in an unconventional way – through the late ocean explorer Jacques Cousteau.

Lee never met Cousteau but her dreams of working with him one day led her to pursue a career in science. Initially, Lee completed an undergraduate degree in marine biology; eventually, her interests changed and she decided to get a dual doctoral degree in physiology and toxicology at Duke University. She now works at Pfizer's R&D site in Boulder, CO (formerly Array BioPharma), leading a group of scientists who determine the safety and efficacy of new oncology drugs.

"Scientists focused on drug discovery and development in the pharmaceutical industry are deeply committed to inventing new therapies to meet unmet needs," Lee says, describing her field of work. "We're driven to achieve new medicines and vaccines as quickly as possible without sacrificing safety."

Among the drugs Lee has helped develop during her career, including cancer therapies, she says around a dozen are currently in development, while nine have received FDA approval — an incredible accomplishment as many scientists spend their careers without seeing their drug make it to market. Lee's team is particularly interested in therapies for brain metastases — something that Lee says is a largely unmet need in cancer research, and something her team is working on from a variety of angles. "Now that we've had rapid success with mRNA vaccine technology, we hope to explore what the future holds when applying this technology to cancers," Lee says.

But while evaluating potential cancer therapies is a professional passion of Lee's, it's also a mission that's deeply personal. "I'm also a breast cancer survivor," she says. "So I've been on the other side of things and have participated in a clinical trial."

However, seeing how melanoma therapies that she helped develop have affected other real-life cancer patients, she says, has been a highlight of her career. "We had one therapy that was approved for patients with BRAF-mutant metastatic melanoma," Lee recalls. "Our team in Boulder was graced by a visit from a patient that had benefited from these drugs that we developed. It was a very special moment for the entire team."

None of these therapies would be available, Lee says without rigorous science behind it: "Facts come from good science. Facts will drive the development of new drugs, and that's what will help patients."

Chiuying "Cynthia" Kuk (they/them) MS, 34, third-year medical student at Michigan State University College of Human Medicine

Photo courtesy of Cynthia Kuk

Cynthia Kuk was just 10 years old when they had a conversation that would change their life forever.

"My mother, who worked as a translator for the government at the time, had been diagnosed with breast cancer, and after her chemotherapy treatments she would get really sick," Kuk, who uses they/them pronouns, recalls. "When I asked my dad why mom was puking so much, he said it was because of the medicine she was taking that would help her get better."

Kuk's response was immediate: "That's so stupid! Why would a medicine make you feel worse instead of better? When I'm older, I want to create medicine that won't make people sick like that."

Nine years later, Kuk traveled from their native Hong Kong to the United States to do exactly that. Kuk enrolled in a small, liberal arts college for their Bachelor's degree, and then four years later started a PhD program in cancer research. Although Kuk's mother was in remission from her cancer at the time, Kuk's goal was the same as it had been as a 10-year-old watching her suffer through chemotherapy: to design a better cancer treatment, and change the landscape of cancer research forever.

Since then, Kuk's mission has changed slightly.

"My mom's cancer relapsed in 2008, and she ended up passing away about five years after that," Kuk says. "After my mom died, I started having this sense of urgency. Cancer research is such that you work for twenty years, and at the end of it you might have a fancy medication that could help people, but I wanted to help people now." With their mother still at the forefront of their mind, Kuk decided to quit their PhD program and enter medical school.

Now, Kuk plans to pursue a career in emergency medicine – not only because they are drawn to the excitement of the emergency room, but because the ER is a place where the most marginalized people tend to seek care.

"I have a special interest in the LGBTQ+ population, as I identify as queer and nonbinary," says Kuk. "A lot of people in this community and other marginalized communities access care through the ER and also tend to avoid medical care since there is a history of mistreatment and judgement from healthcare workers. How you carry yourself as a doctor, your compassion, that can make a huge difference in someone's care."

In addition to making a difference in the lives of LGBTQ+ patients, Kuk wants to make a difference in the lives of patients with cancer as well, like their mother had.

"We've diagnosed patients in the Emergency Department with cancer before," Kuk says. "I can't make cancer good news but how you deliver bad news and the compassion you show could make a world of difference to that patient and their family."

During their training, Kuk advocates for patients by delivering compassionate and inclusive care, whether they happen to have cancer or not. In addition to emphasizing their patient's pronouns and chosen names, they ask for inclusive social and sexual histories as well as using gender neutral language. In doing this, they hope to make medicine as a whole more accessible for people who have been historically pushed aside.

"I'm just one person, and I can't force everyone to respect you, if you're marginalized," Kuk says. "But I do want to push for a culture where people appreciate others who are different from them."